Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25974441 | 0.81 | RET (0.34) | OXTRAVPR1A | |
| SCHEMBL25974321 | 0.77 | MKNK2 (0.35) | OXTRAVPR1A | |
| SCHEMBL26030890 | 0.77 | MKNK2 (0.36) | OXTR | |
| SCHEMBL25974427 | 0.76 | MKNK2 (0.37) | OXTRAVPR1A | |
| SCHEMBL25974309 | 0.74 | PDE2A (0.35) | OXTRAVPR1A | |
| SCHEMBL18306468 | 0.74 | L3MBTL1 (0.39) | OXTR | |
| SCHEMBL26030886 | 0.74 | ALDH1A1 (0.40) | OXTR | |
| SCHEMBL25974447 | 0.72 | LMNA (0.39) | OXTR | |
| SCHEMBL25974449 | 0.69 | IL1B (0.37) | OXTR | |
| SCHEMBL13086666 | 0.68 | TUBB1 (0.39) | OXTRAVPR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023154282-A1 | COMPOUNDS HAVING A T-STRUCTURE FORMED BY AT LEAST FOUR CYCLES FOR USE IN THE TREATMENT OF CANCER AND OTHER INDICATIONS | THERAS, INC. (US) | 2023-08-17 | — | — | WO | disclosed |